Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2
Authors
Scott Plotkin•Anat Stemmer‐Rachamimov•Emmanuelle Tomaso
Journal
New England Journal of Medicine
Published
July 8, 2009
Abstract
Profound hearing loss is a serious complication of neurofibromatosis type 2, a genetic condition associated with bilateral vestibular schwannomas, benign tumors that arise from the eighth cranial nerve. There is no medical treatment for such tumors.